Leptomeningeal Metastatic L858R EGFR-mutant Lung Cancer: Prompt Response to Osimertinib in the Absence of T790M-mutation and Effective Subsequent Pulsed Erlotinib

Leptomeningeal carcinomatosis (LMC) is a known sequel of metastatic lung cancer and its treatment is challenging. Nevertheless, treatment options for LMC due to metastatic epidermal growth factor receptor-mutant (EGFR-mutant) lung adenocarcinoma are expanding. We present a 52-year-old male patient w...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanbour, Aladdin, Salih, Faroug, Abualainin, Wafa, Abdelrazek, Mohamed, Szabados, Lajos, Al-Bozom, Issam, Omar, Nabil E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9207126/
https://www.ncbi.nlm.nih.gov/pubmed/35733652
http://dx.doi.org/10.2147/OTT.S336012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9207126/
https://www.ncbi.nlm.nih.gov/pubmed/35733652
http://dx.doi.org/10.2147/OTT.S336012

Ejemplares similares